Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Severe or Acute inflammation Age: Adult Condition: Initial therapy |
Dose: Eye drops – 1 or 2 drops Frequency: Every 30 to 60 minutes Note: Reduce the dosage when a favourable response is observed to every two to four hours; in the conjunctival sac. |
|
Indication: Severe or Acute inflammation Age: Adult Condition: Following favourable response |
Dose: Eye drops – 1 or 2 drops Frequency: Every two to four hours Note: In the conjunctival sac. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Inflammatory ocular conditions Age: 2 years or older |
Dose: Ophthalmic drops – 1 to 2 drops Frequency: Up to 4 to 6 times a day; may use hourly in severe disease and taper to discontinuation Note: Route: Ophthalmic |
Administration
- Clean area before use
- Apply as directed
Side Effect
- Cataract (4% )
- Ocular hypertension
- Open-angle glaucoma
- optic nerve damage
- and defects in visual acuity and field of vision (after prolonged use)
- Transient ocular stinging
- burning
- local irritation
- ocular discharge
- ocular discomfort or pain
- foreign body sensation
- hyperemia
- abnormal vision/blurring
- pruritus
- lid margin crusting
- sticky sensation
- increased fibrin
- dry eye
- conjunctival edema
- corneal staining
- keratitis
- tearing
- edema
- irritation
- corneal ulcer
- browache
- eyelid erythema
- corneal edema
- infiltrate
- corneal erosion
- mydriasis
- ptosis
- epithelial punctate keratitis
- and possible corneal or scleral malacia
- [posterior subcapsular cataracts] (prolonged use)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Epithelial Herpes Simplex
|
May worsen viral infection
|
|
Vaccinia
|
Can worsen infection
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30° C in a cool and dry place protected from light. Keep out of reach of children. Do not touch the dropper tip to surfaces since this may contaminate the solution. Do not use after 30 days of first opening.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.